India's major success against bird flu, first indigenous H5N1 vaccine prepared for chickens
For the first time in the country, an indigenous H5N1 vaccine has been developed to protect chickens from bird flu. Prepared by the Bhopal-based ICAR-National Institute of High Security Animal Diseases (NIHSAD), Union Minister for Agriculture and Farmers Welfare Shivraj Singh Chouhan will dedicate this vaccine to the nation on November 20.

To prevent the heavy losses caused every year to the poultry business due to bird flu, India has achieved a major milestone. For the first time in the country, an indigenous H5N1 vaccine has been developed to protect chickens from bird flu. Prepared by the Bhopal-based ICAR-National Institute of High Security Animal Diseases (NIHSAD), Union Minister for Agriculture and Farmers Welfare Shivraj Singh Chouhan will dedicate this vaccine to the nation on November 20.
An official statement in this regard has been issued by the Ministry of Agriculture and Farmers Welfare. According to it, the inactivated H5N1 (clade 2.3.2.1A) vaccine prepared for chickens is the first indigenous vaccine of its kind in India. It has been specially developed to provide protection against clade 2.3.2.1A of the H5N1 HPAI virus spreading in the country.
In fact, bird flu is also called Highly Pathogenic Avian Influenza (HPAI). It is a serious disease affecting chickens and other birds. Due to its infection, the mortality rate in birds can be up to 100 percent. When the disease breaks out, a large number of birds have to be culled and restrictions are also imposed on the trade of poultry products. This causes heavy financial losses to poultry farmers.
Bird flu could cause heavy economic losses to the country
According to the central government, a major outbreak of bird flu can affect India's GDP growth rate by up to 1.5 percent. If this disease spreads out of control, there is a risk of more than 20 percent of the country's poultry population being affected and destroyed.
According to data, in the year 2006, India suffered a direct and indirect loss of about Rs 2,200 to 3,000 crore due to the bird flu outbreak. Similarly, during an outbreak of bird flu in Manipur, an economic loss equivalent to 0.5 percent of the state's GDP was recorded.
Infection cases have also surfaced in humans
Bird flu is not only a threat to birds and the poultry business, but it is also a matter of concern for human health. According to World Health Organization (WHO) data, from 2003 to date, 1,003 cases of H5N1 avian influenza have been reported in humans across 25 countries including India, out of which 479 people have died.
According to the ministry, clade 2.3.2.1A of the H5N1 virus has been responsible for most of the bird flu outbreaks in chickens. In recent times, infection with this virus has also been observed in several animal species, especially mammals. Apart from this, three cases of this virus have also been reported in humans.
Why was an indigenous vaccine necessary?
According to the central government, currently no specific commercial vaccine was available for protection against clade 2.3.2.1A of the H5N1 virus. Due to this, it was extremely important for India to develop its own vaccine.
This indigenous vaccine prepared by the Bhopal-based ICAR-National Institute of High Security Animal Diseases is an important step towards fulfilling this need. Its main objective is to provide protection to chickens from bird flu, reduce the economic losses of poultry farmers and minimize the risk of the virus spreading to other animals and humans.
Key developments
- First indigenous H5N1 vaccine developed for chickens in the country.
- It has been prepared by Bhopal-based ICAR-NIHSAD.
- Union Minister Shivraj Singh Chouhan will dedicate the vaccine to the nation on November 20.
- The vaccine will protect against clade 2.3.2.1A of the H5N1 virus.



